Sea Harvest Group Limited (JSE:SHG)

CTI BioPharma Ratios and Metrics

Market cap in millions ZAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,627	2,802	2,609	3,358	3,926	3,989
Market Cap Growth	7.40%	7.40%	-22.32%	-14.45%	-1.59%	-1.10%
Enterprise Value	5,895	6,239	5,381	5,890	5,434	5,736
Last Close Price	7.80	8.08	8.72	10.64	11.75	11.79
PE Ratio	10.99	12.35	9.25	10.81	8.36	9.26
Forward PE	7.57	6.59	6.32	7.49	7.92	10.20
PS Ratio	0.37	0.39	0.42	0.57	0.85	0.91
PB Ratio	0.66	0.71	0.77	1.04	1.24	1.43
P/TBV Ratio	2.07	2.21	3.12	4.50	2.66	3.44
P/FCF Ratio	41.34	44.09	-	22.46	13.33	8.70
P/OCF Ratio	3.39	3.62	5.80	7.00	6.16	4.92
PEG Ratio	-	0.65	0.65	0.65	0.65	0.65
EV/Sales Ratio	0.82	0.87	0.87	1.00	1.18	1.31
EV/EBITDA Ratio	6.21	6.85	7.38	8.27	5.95	6.93
EV/EBIT Ratio	9.78	10.38	11.70	12.55	7.89	9.15
EV/FCF Ratio	92.77	98.18	-	39.39	18.45	12.50
Debt / Equity Ratio	0.91	0.91	0.86	0.82	0.65	0.57
Debt / EBITDA Ratio	3.81	3.81	3.79	3.58	2.21	1.88
Debt / FCF Ratio	56.87	56.87	-	17.65	7.00	3.47
Asset Turnover	0.80	0.80	0.79	0.81	0.73	0.77
Inventory Turnover	4.45	4.45	4.59	4.74	4.16	4.77
Quick Ratio	0.79	0.79	0.91	0.93	1.29	1.09
Current Ratio	1.88	1.88	1.89	1.96	2.35	2.03
Return on Equity (ROE)	6.26%	6.26%	8.14%	9.18%	14.56%	14.99%
Return on Assets (ROA)	4.21%	4.21%	3.67%	4.05%	6.82%	6.93%
Return on Capital (ROIC)	5.43%	5.43%	4.74%	5.28%	8.95%	9.09%
Return on Capital Employed (ROCE)	7.40%	7.40%	6.80%	7.30%	12.00%	12.70%
Earnings Yield	8.64%	8.10%	10.81%	9.25%	11.97%	10.80%
FCF Yield	2.42%	2.27%	-3.44%	4.45%	7.50%	11.50%
Dividend Yield	2.89%	2.72%	4.59%	3.57%	4.77%	3.82%
Payout Ratio	30.99%	53.25%	39.35%	54.53%	28.07%	30.54%
Buyback Yield / Dilution	-13.69%	-13.69%	1.16%	-1.34%	2.43%	-0.60%
Total Shareholder Return	-10.80%	-10.96%	5.75%	2.23%	7.19%	3.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.